Cite

HARVARD Citation

    Cesne, A. et al. (n.d.). Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial. Lancet oncology. 16 (3), pp. 312-319. [Online]. 
  
Back to record